Sign inJoin waitlistJoin the waitlist

Samir Undevia

Physician · Endeavor Health

Credentials: · · · ·

History

Endeavor Health
2024–Present

Hematology and Medical Oncology
University of Chicago Medical Center
2000–2003
Internal Medicine
University of Chicago Medical Center
1997–2000
New York University Grossman School of Medicine
1993–1997

Research

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan
Journal of Clinical Oncology · 2004 · 764 citations
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
Journal of Clinical Oncology · 2009 · 450 citations
Pharmacokinetic variability of anticancer agents
Review · Nature reviews. Cancer · 2005 · First of 3 authors · 182 citations

Mark Ratain
17 papers
Bruce Brockstein
4 papers
MM
Michael Maitland
4 papers
NV
Nicholas Vogelzang
4 papers
Richard Schilsky
4 papers
Walter Stadler
4 papers
Everett Vokes
3 papers
Gary Schwartz
3 papers
Hedy Kindler
3 papers
RM
Robert Maki
3 papers
SS
Scott Schuetze
3 papers
Wendy Stock
3 papers

Clinical trials

Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
Principal investigator · Completed · Phase 1
Pharmacyclics LLC.
2007–2010
Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients
Principal investigator · Completed · Phase 1
Pharmacyclics LLC.
2005–2007
Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2003
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2032